Clinical Trials Directory

Trials / Terminated

TerminatedNCT05510128

Evaluation of the Effectiveness of a Protocol for the Management of Female Functional Urinary Signs

Evaluation of the Effectiveness of the Application of a Protocol for the Management of Female Functional Urinary Signs in French Community Pharmacies

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
145 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Every year, between 4 and 6 million French people are affected by a urinary infection; the vast majority of these are women. Although the diagnosis of an uncomplicated urinary tract infection is simple to make, it requires prompt medical management to relieve the symptoms. The lack of immediate of a physician can slow down the management of patients affected by this condition, and lead to an inappropriate referral of patients to the emergency services. Because of their wide availability, accessibility, and geographical distribution throughout the country, pharmacists are primary health care professionals who are regularly called upon to respond to patients with this type of infection. A national protocol exists in France, but it is very difficult to apply. The PharmaCyst' study aims to evaluate its application in community pharmacies.

Conditions

Interventions

TypeNameDescription
OTHERPharmacist managementWhen a patient comes to the pharmacy with signs of urinary burning, the following will follow: * Completion of the acute cystitis symptoms score (ACSS) questionnaire. * Measure the temperature. * Perform a urine dipstick. If the patient's temperature is normal, the urine dipstick is positive, and the absence of pain in the lumbar fossa is verified, the pharmacist can dispense an appropriate antibiotic himself. A reminder of the hygienic-dietary rules is also issued, and a communication to the patient's general practitioner will be made.

Timeline

Start date
2023-06-30
Primary completion
2024-10-29
Completion
2025-01-29
First posted
2022-08-22
Last updated
2026-03-13

Locations

14 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05510128. Inclusion in this directory is not an endorsement.